TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) just unveiled an announcement.
KYORIN Pharmaceutical Co., Ltd. reported a significant decline in its financial performance for the nine months ended December 31, 2024, with a notable decrease in profits compared to the previous year. The company has changed its accounting policies, affecting year-on-year comparisons, and anticipates modest growth in sales and operating profit for the full fiscal year ending March 31, 2025.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of medical products. The company is known for its innovative solutions in healthcare, targeting both domestic and international markets.
YTD Price Performance: -5.05%
Average Trading Volume: 83,221
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen81.83B
See more insights into 4569 stock on TipRanks’ Stock Analysis page.